Driehaus Capital Management’s Alpine Immune Sciences Inc ALPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-23,566
Closed -$934K – 457
2024
Q1
$934K Hold
23,566
– – 0.01% 321
2023
Q4
$449K Buy
23,566
+4,930
+26% +$68.5K 0.01% 343
2023
Q3
$213K Buy
+18,636
New +$229K ﹤0.01% 384
2015
Q4
– Sell
-40,524
Closed -$2.1M – 657
2015
Q3
$2.1M Sell
40,524
-31,109
-43% -$2.04M 0.08% 274
2015
Q2
$4.34M Buy
+71,633
New +$4.27M 0.15% 165

Driehaus Capital Management's ALPN Position: Q2 2024 in Review

Driehaus Capital Management sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 23,566 shares — an estimated $934K sold.

Driehaus Capital Management first reported a position in ALPN in Q2 2015 and held it in 5 quarters. The position peaked at $4.34M in Q2 2015. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

  • Driehaus Capital Management reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
  • Driehaus Capital Management sold 23,566 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $934K.
  • Driehaus Capital Management first reported a position in Alpine Immune Sciences Inc in Q2 2015 and held it in 5 quarters.
  • Driehaus Capital Management's Alpine Immune Sciences Inc position peaked at $4.34M in Q2 2015.
  • 0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on Driehaus Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.